Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 64

References for PMC Articles for PubMed (Select 19375170)

1.

Estimated 10-year stroke risk by region and race in the United States: geographic and racial differences in stroke risk.

Cushman M, Cantrell RA, McClure LA, Howard G, Prineas RJ, Moy CS, Temple EM, Howard VJ.

Ann Neurol. 2008 Nov;64(5):507-13. doi: 10.1002/ana.21493.

2.

Effect of the selective serotonin reuptake inhibitor paroxetine on platelet function is modified by a SLC6A4 serotonin transporter polymorphism.

Abdelmalik N, Ruhé HG, Barwari K, van den Dool EJ, Meijers JC, Middeldorp S, Büller HR, Schene AH, Kamphuisen PW.

J Thromb Haemost. 2008 Dec;6(12):2168-74. doi: 10.1111/j.1538-7836.2008.03196.x. Epub 2008 Oct 18.

PMID:
18983505
3.

How the serotonin story is being rewritten by new gene-based discoveries principally related to SLC6A4, the serotonin transporter gene, which functions to influence all cellular serotonin systems.

Murphy DL, Fox MA, Timpano KR, Moya PR, Ren-Patterson R, Andrews AM, Holmes A, Lesch KP, Wendland JR.

Neuropharmacology. 2008 Nov;55(6):932-60. doi: 10.1016/j.neuropharm.2008.08.034. Epub 2008 Sep 11. Review.

4.

Escitalopram and problem-solving therapy for prevention of poststroke depression: a randomized controlled trial.

Robinson RG, Jorge RE, Moser DJ, Acion L, Solodkin A, Small SL, Fonzetti P, Hegel M, Arndt S.

JAMA. 2008 May 28;299(20):2391-400. doi: 10.1001/jama.299.20.2391. Erratum in: JAMA. 2009 Mar 11;301(10):1024.

5.

Antidepressant therapy in post-stroke depression.

Starkstein SE, Mizrahi R, Power BD.

Expert Opin Pharmacother. 2008 Jun;9(8):1291-8. doi: 10.1517/14656566.9.8.1291 . Review.

PMID:
18473704
6.

Macromolecular white matter abnormalities in geriatric depression: a magnetization transfer imaging study.

Gunning-Dixon FM, Hoptman MJ, Lim KO, Murphy CF, Klimstra S, Latoussakis V, Majcher-Tascio M, Hrabe J, Ardekani BA, Alexopoulos GS.

Am J Geriatr Psychiatry. 2008 Apr;16(4):255-62. doi: 10.1097/JGP.0b013e3181602a66.

PMID:
18378551
7.

Antidepressant treatment and worsening white matter on serial cranial magnetic resonance imaging in the elderly: the Cardiovascular Health Study.

Steffens DC, Chung H, Krishnan KR, Longstreth WT Jr, Carlson M, Burke GL.

Stroke. 2008 Mar;39(3):857-62. doi: 10.1161/STROKEAHA.107.498097. Epub 2008 Jan 31.

8.

Microstructural white matter abnormalities and remission of geriatric depression.

Alexopoulos GS, Murphy CF, Gunning-Dixon FM, Latoussakis V, Kanellopoulos D, Klimstra S, Lim KO, Hoptman MJ.

Am J Psychiatry. 2008 Feb;165(2):238-44. doi: 10.1176/appi.ajp.2007.07050744. Epub 2008 Jan 2.

PMID:
18172016
9.

The serotonin transporter gene and effectiveness of SSRIs.

Serretti A, Kato M.

Expert Rev Neurother. 2008 Jan;8(1):111-20. Review.

PMID:
18088204
10.

Serotonin transporter (5-HTTLPR) genotype and amygdala activation: a meta-analysis.

Munafò MR, Brown SM, Hariri AR.

Biol Psychiatry. 2008 May 1;63(9):852-7. Epub 2007 Oct 22. Erratum in: Biol Psychiatry. 2009 Aug 1;66(3):302.

11.

Short/long heterozygotes at 5HTTLPR and white matter lesions in geriatric depression.

Steffens DC, Taylor WD, McQuoid DR, Krishnan KR.

Int J Geriatr Psychiatry. 2008 Mar;23(3):244-8.

PMID:
17702053
12.

Serotonin transporter polymorphism, memory and hippocampal volume in the elderly: association and interaction with cortisol.

O'Hara R, Schröder CM, Mahadevan R, Schatzberg AF, Lindley S, Fox S, Weiner M, Kraemer HC, Noda A, Lin X, Gray HL, Hallmayer JF.

Mol Psychiatry. 2007 Jun;12(6):544-55. Epub 2007 Mar 13.

13.

Relationship between white matter fractional anisotropy and other indices of cerebral health in normal aging: tract-based spatial statistics study of aging.

Kochunov P, Thompson PM, Lancaster JL, Bartzokis G, Smith S, Coyle T, Royall DR, Laird A, Fox PT.

Neuroimage. 2007 Apr 1;35(2):478-87. Epub 2006 Dec 23.

PMID:
17292629
14.

Analysis of association between the serotonin transporter and antidepressant response in a large clinical sample.

Kraft JB, Peters EJ, Slager SL, Jenkins GD, Reinalda MS, McGrath PJ, Hamilton SP.

Biol Psychiatry. 2007 Mar 15;61(6):734-42. Epub 2006 Nov 21.

PMID:
17123473
15.

Association of a triallelic serotonin transporter gene promoter region (5-HTTLPR) polymorphism with stressful life events and severity of depression.

Zalsman G, Huang YY, Oquendo MA, Burke AK, Hu XZ, Brent DA, Ellis SP, Goldman D, Mann JJ.

Am J Psychiatry. 2006 Sep;163(9):1588-93.

PMID:
16946185
16.

Serotonin transporter gene status predicts caudate nucleus but not amygdala or hippocampal volumes in older persons with major depression.

Hickie IB, Naismith SL, Ward PB, Scott EM, Mitchell PB, Schofield PR, Scimone A, Wilhelm K, Parker G.

J Affect Disord. 2007 Feb;98(1-2):137-42. Epub 2006 Aug 23.

PMID:
16930719
17.

Virchow-Robin space dilatation may predict resistance to antidepressant monotherapy in elderly patients with depression.

Patankar TF, Baldwin R, Mitra D, Jeffries S, Sutcliffe C, Burns A, Jackson A.

J Affect Disord. 2007 Jan;97(1-3):265-70. Epub 2006 Aug 17.

PMID:
16919335
18.

Serotonin transporter promoter gain-of-function genotypes are linked to obsessive-compulsive disorder.

Hu XZ, Lipsky RH, Zhu G, Akhtar LA, Taubman J, Greenberg BD, Xu K, Arnold PD, Richter MA, Kennedy JL, Murphy DL, Goldman D.

Am J Hum Genet. 2006 May;78(5):815-26. Epub 2006 Mar 28.

19.

Tract-based spatial statistics: voxelwise analysis of multi-subject diffusion data.

Smith SM, Jenkinson M, Johansen-Berg H, Rueckert D, Nichols TE, Mackay CE, Watkins KE, Ciccarelli O, Cader MZ, Matthews PM, Behrens TE.

Neuroimage. 2006 Jul 15;31(4):1487-505. Epub 2006 Apr 19.

PMID:
16624579
20.

Imaging genetics: perspectives from studies of genetically driven variation in serotonin function and corticolimbic affective processing.

Hariri AR, Drabant EM, Weinberger DR.

Biol Psychiatry. 2006 May 15;59(10):888-97. Epub 2006 Jan 25. Review.

PMID:
16442081
Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk